Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"HBsAg levels"”.
-
Επίπεδα HBsAg ορού σε ασθενείς με HBeAg-αρνητική χρόνια ηπατίτιδα Β υπό μακροχρόνια αντιική θεραπεία
Background/Aims: Serum HBsAg levels might be used as predictor of virological breakthrough or of sustained off-treatment virological response in HBeAg-negative chronic hepatitis B (CHB) patients. We evaluated the changes of HBsAg in those patients under nucleos(t)ide analogue(s) [NA(s)] therapy for …
-
Πρόωρος τοκετός και βάρος γέννησης νεογνών γυναικών με χρόνια λοίμωξη από τον ιό ηπατίτιδας Β
… activity parameters (maternal HBV-DNA levels / HBsAg quantification). The aim of the study was to evaluate the preterm birth rates as well as the birth weight of full term neonates from chronic HBV infected pregnant women compared to uninfected women..Methods: A total of 1800 …
-
To Stop or Not to Stop: Response After Nucleos(t)ide Analogue Withdrawal Among Patients With Chronic Hepatitis B
… treatment, and hepatitis B surface antigen (HBsAg) loss, or “functional cure” is rare on therapy. NA withdrawal results in higher rates of HBsAg loss but remains controversial because of the possibility of HBV flares. This thesis aims to investigate long-term outcomes after NA cessation and …
-
Investigating the role of novel Hepatitis B markers in predicting clinical outcomes in Chronic Hepatitis B patients
… still 10% of mothers with highly active virus levels pass the infection to their infants. <br/><br/>This thesis investigates the role of serological and virological markers in predicting long term clinical outcomes in patients suffering from chronic hepatitis B virus infection who acquired it …
-
Characterisation of HBV and SARS-CoV-2 spike specific T cells and their association with viral control
… were associated with HBeAg clearance and lower HBsAg levels. X146-154-specific CD8+ T cells can produce effector cytokines and express CD107a when encountering HBV-infected HepG2<sup>hNTCP</sup> cells. Furthermore, they can kill HBV-infected cells and suppress HBV replication and antigen …